Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for Ascendis Pharma (ASND): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
23 analysts
Options Flow (P/C)
0.91
More calls — Bullish
Avg Consensus PT
$299
+26.5%
Highest Price Target
$355
+50.0%
Lowest Price Target
$181
-23.5%
Short Interest
7.6%
Rising — Bearish
Insider Activity (30d)
Net Seller
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Sep 15, 2026 | Raymond James | Martin Auster— | +21.2% | $287 → $287 | Downgrade | Strong Buy→Outperform |
| Sep 2, 2026 | Oppenheimer | Leland Gershell— | +31.8% | $304 → $312 | Maintained | Outperform |